07.05.2014 • Topicscdl-opinionsManfred FischerMerck

A Global Company Needs Globally Harmonized Systems

Manfred Fischer, vice president distribution chemicals, Merck
Manfred Fischer, vice president distribution chemicals, Merck

Complexity management and standardization

M. Fischer: Merck is a global pharmaceutical and chemical company that operates in a highly regulated market. The complexity of the supply chain is continuously growing. More and more countries are issuing their own dangerous-good handling requirements, which are not globally harmonized. Country-specific formats and handling requirements are the result, and this is increasing both complexity and cost enormously. Country-specific labeling in local languages and specific import processes are two examples.

At the same time, customers want specific packaging designs, delivery conditions, labels and documentation. Customers that operate globally require from their suppliers globally harmonized standards, for instance standardized quality, delivery documents and barcodes. Increasing complexity leads to increasing cost pressure.

How can a company like Merck deal with increasing demands such as these? The answer is: through more standardization of processes and master data supported by a globally harmonized IT system. At the same time, logistics processes of a global company need to be managed globally as well.

Merck uses several transport and warehousing service providers. More collaboration with them is necessary in order to meet customer expectations. Therefore, our strategy is to reduce the total number of service providers to be able to increase the level of collaboration. Using IT interfaces and a track-and-trace system is a must.

With these requirements, making use of ad hoc freight tenders is not possible. We prefer more strategic partnerships with service providers, however, we tender or benchmark our services every two to five years, depending on the type of service concerned.

 

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
19.03.2025 • TopicsStrategy

The Future of Demand for Chemicals

The chemical industry is shifting to sustainability-related products, with demand growing 4.5 times faster than conventional ones. Companies must revise their market strategies to capitalize on this opportunity.

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.